Jiewei Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Dan Xie (20 shared papers)Feng‐Wei Wang (10 shared papers)Xin-Yuan Guan (3 shared papers)Kai Han (5 shared papers)Jing‐Ping Yun (3 shared papers)潘志忠 (4 shared papers)Rixin Chen (2 shared papers)Ning‐Fang Ma (2 shared papers)
- Journals
- Oncogene (3 papers)Signal Transduction and Targeted Therapy (3 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Oncotarget (2 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jiewei Chen
44 papers receiving 1.4k citations
Jiewei Chen's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 494
- Molecular Biology 860
- Oncology 224
- Immunology 125
- Pathology and Forensic Medicine 92
Countries citing papers authored by Jiewei Chen
This map shows the geographic impact of Jiewei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewei Chen more than expected).
Fields of papers citing papers by Jiewei Chen
This network shows the impact of papers produced by Jiewei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewei Chen. The network helps show where Jiewei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiewei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 567 |
| 2 | 2021 | 59 | |
| 3 | 2017 | 58 | |
| 4 | 2019 | 52 | |
| 5 | 2021 | 52 | |
| 6 | 2015 | 50 | |
| 7 | 2020 | 40 | |
| 8 | 1997 | 36 | |
| 9 | 2015 | 34 | |
| 10 | 2018 | 33 | |
| 11 | 2022 | 32 | |
| 12 | 2019 | 28 | |
| 13 | 2017 | 27 | |
| 14 | 2014 | 27 | |
| 15 | 2024 | 27 | |
| 16 | 2021 | 24 | |
| 17 | 2024 | 23 | |
| 18 | 2020 | 19 | |
| 19 | 2021 | 18 | |
| 20 | 2022 | 17 |
About Jiewei Chen
Jiewei Chen is a scholar working on Oncology, Cancer Research, Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Metastasis and carcinoma case studies (4 papers), RNA Research and Splicing (4 papers), Ubiquitin and proteasome pathways (4 papers), Circular RNAs in diseases (3 papers), Cancer-related gene regulation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Cancer Research (494 citations), Molecular Biology (860 citations), Oncology (224 citations), Immunology (125 citations) and Pathology and Forensic Medicine (92 citations). Jiewei Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Dan Xie, Feng‐Wei Wang, Xin-Yuan Guan, Kai Han, Jing‐Ping Yun, 潘志忠, Rixin Chen, Ning‐Fang Ma, Feng Wang and Jiaxing Zhang. Their work appears in journals such as Oncogene, Signal Transduction and Targeted Therapy, Journal of Experimental & Clinical Cancer Research, Oncotarget and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.